drugset / Trial / NCT01306578

Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

NCT01306578 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Comparing whether intravenous immune globulin or plasma exchange is superior in treating mechanically ventilated children with Guillain Barre syndrome.

Timeline

Start
2007-01
Primary completion
2009-12
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator intravenous immunoglobulin Unknown 0.4 g/kg Intravenous